Back
97
72
Day Range
$2.71
$2.80
52-Week Range
$2.60
$4.31
Volume
11,769
50D / 200D Avg
$2.99
/
$3.20
Prev Close
$2.71
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -13.7 | 0.4 |
| P/B | 0.8 | 2.9 |
| ROE % | -5.8 | 3.7 |
| Net Margin % | -3.6 | 3.8 |
| Rev Growth 5Y % | 46.7 | 10.0 |
| D/E | 0.8 | 0.2 |
Key Takeaways
Revenue grew 46.67% annually over 5 years — strong growth
Earnings declined -253.85% over the past year
Generating 87.85M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.45%
Capital efficient — spends only 1.99% of revenue on capex
ROIC of 29.48% — excellent capital efficiency
Growth
Revenue Growth (5Y)
46.67%
Revenue (1Y)52.12%
Earnings (1Y)-253.85%
FCF Growth (3Y)22.72%
Quality
Return on Equity
-5.80%
ROIC29.48%
Net Margin-3.59%
Op. Margin44.20%
Safety
Debt / Equity
0.82
Current Ratio1.03
Interest Coverage11.36
Valuation
P/E Ratio
-13.73
P/B Ratio0.80
EV/EBITDA2.05
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 52.12% | Revenue Growth (3Y) | 34.27% |
| Earnings Growth (1Y) | -253.85% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 46.67% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.40B | Net Income (TTM) | -50.17M |
| ROE | -5.80% | ROA | -2.39% |
| Gross Margin | 37.50% | Operating Margin | 44.20% |
| Net Margin | -3.59% | Free Cash Flow (TTM) | 87.85M |
| ROIC | 29.48% | FCF Growth (3Y) | 22.72% |
| Safety | |||
| Debt / Equity | 0.82 | Current Ratio | 1.03 |
| Interest Coverage | 11.36 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -13.73 | P/B Ratio | 0.80 |
| P/S Ratio | 0.49 | PEG Ratio | 1.09 |
| EV/EBITDA | 2.05 | Dividend Yield | 0.00% |
| Market Cap | 689.04M | Enterprise Value | 1.27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.40B | 919.69M | 776.05M | 569.14M | 302.32M |
| Net Income | -50.17M | 32.61M | 82,000.0 | 1.37M | -43.79M |
| EPS (Diluted) | -0.03 | 0.13 | 0.00 | 0.01 | -0.23 |
| Gross Profit | 524.65M | 363.01M | 372.27M | 303.29M | 153.70M |
| Operating Income | 618.34M | -30.20M | 35.16M | 23.31M | -12.79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.10B | 1.81B | 1.41B | 1.32B | 1.26B |
| Total Liabilities | 1.06B | 877.55M | 563.16M | 503.78M | 554.37M |
| Shareholders' Equity | 862.80M | 867.61M | 767.67M | 732.34M | 618.24M |
| Total Debt | 710.38M | 425.09M | 426.28M | 358.42M | 401.94M |
| Cash & Equivalents | 133.65M | 131.67M | 43.42M | 48.91M | 61.92M |
| Current Assets | 369.30M | 346.11M | 176.40M | 150.88M | 142.91M |
| Current Liabilities | 357.17M | 382.08M | 152.95M | 136.50M | 137.30M |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#2 of 616
Custom
Full Throttle
#11 of 146
Recent Activity
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Full Throttle
Mar 24, 2026